The deficiency in apolipoproteins levels in COVID-19 compared to normal human plasma (NHP) and ICU-ARDS patients was most pronounced for APOA1, APOA2, APOA4, APOC3 and APOE (Table 2). This evidence concerns the gene APOA4 and acute respiratory distress syndrome.